KCAS Bio
The Sr. Scientist in the Mass Spec Bioanalysis Production group at KCAS Bio will lead regulated bioanalytical studies, overseeing sample preparation, LC‑MS/MS analysis, data review, and reporting in a GLP‑compliant environment. The role includes providing technical guidance to junior staff, managing client communications, and ensuring compliance with protocols, SOPs, and regulatory requirements.
Headquarters
Olathe, Kansas, United States
Company Size
201-500 employees
Founded
1979
KCAS Bio is a bioanalytical contract research organization (CRO) that supports drug development worldwide across complex therapeutic modalities. They provide GLP/GCP‑compliant bioanalytical services—including PK/PD analysis, method development and validation, immunogenicity and biomarker assays, and regulated sample testing—for small molecules, biologics, and advanced therapies. Clients rely on KCAS Bio for experienced scientific teams, robust quality and regulatory systems, and global project management to accelerate programs from discovery through clinical development.
The KCAS Bio – Lyon, France Site Renews Its GLP Compliance Statement, Strengthening Its Support for IND-Enabling Studies Through Bioanalysis and Biomarkers
3 days ago
KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle
Nov 3, 2025
2025 Champions of Business: KCAS Bio
May 30, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for KCAS Bio.
KCAS Bio didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
KCAS Expands Its Transatlantic Presence with the Acquisition of France-based Active Biomarkers
Sep 12, 2022